These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The role of the microbiome in NAFLD and NASH. Kolodziejczyk AA; Zheng D; Shibolet O; Elinav E EMBO Mol Med; 2019 Feb; 11(2):. PubMed ID: 30591521 [TBL] [Abstract][Full Text] [Related]
7. Gut microbiota abnormalities, small intestinal bacterial overgrowth, and non-alcoholic fatty liver disease: An emerging paradigm. Ghoshal UC; Goel A; Quigley EMM Indian J Gastroenterol; 2020 Feb; 39(1):9-21. PubMed ID: 32291578 [TBL] [Abstract][Full Text] [Related]
8. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma. Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237 [TBL] [Abstract][Full Text] [Related]
10. Nisin lantibiotic prevents NAFLD liver steatosis and mitochondrial oxidative stress following periodontal disease by abrogating oral, gut and liver dysbiosis. Kuraji R; Ye C; Zhao C; Gao L; Martinez A; Miyashita Y; Radaic A; Kamarajan P; Le C; Zhan L; Range H; Sunohara M; Numabe Y; Kapila YL NPJ Biofilms Microbiomes; 2024 Jan; 10(1):3. PubMed ID: 38233485 [TBL] [Abstract][Full Text] [Related]
11. Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH). Ota T Adv Exp Med Biol; 2021; 1261():223-229. PubMed ID: 33783745 [TBL] [Abstract][Full Text] [Related]
12. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310 [TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease and periodontal disease: A systematic review and meta-analysis of cross-sectional studies. Aguiar ILS; Santos-Lins LS; Brasil-Oliveira R; Cotrim HP; Lins-Kusterer L Arab J Gastroenterol; 2023 Nov; 24(4):198-203. PubMed ID: 37993376 [TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question. Streba LA; Vere CC; Rogoveanu I; Streba CT World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859 [TBL] [Abstract][Full Text] [Related]
16. The Role of Gut-Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC. Song Q; Zhang X Biomedicines; 2022 Feb; 10(3):. PubMed ID: 35327326 [TBL] [Abstract][Full Text] [Related]
17. New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis. Pydyn N; Miękus K; Jura J; Kotlinowski J Pharmacol Rep; 2020 Feb; 72(1):1-12. PubMed ID: 32016853 [TBL] [Abstract][Full Text] [Related]
18. Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease. Aqel B; DiBaise JK Nutr Clin Pract; 2015 Dec; 30(6):780-6. PubMed ID: 26449892 [TBL] [Abstract][Full Text] [Related]